AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Protector Forsikring

Investor Presentation Apr 27, 2022

3719_rns_2022-04-27_7aabb115-7543-4318-9ed6-25ba451619f9.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Investor Presentation

Henrik Høye Chief Executive Officer

Disclaimer

This presentation and the information contained herein have been prepared by and is the sole responsibility of Protector Forsikring ASA (the "Company"). Such information is being provided to you solely for your information and may not be reproduced, retransmitted, further distributed to any other person or published, in whole or in part, for any purpose. Failure to comply with this restriction may constitute a violation of applicable securities laws. The information and opinions presented herein are based on general information gathered at the time of writing and are therefore subject to change without notice. The Company assumes no obligationsto update or correct any of the information set out herein.

These materials may contain statements about future events and expectations that are forward-looking statements. Any statement in these materials that is not a statement of historical fact including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations is a forward-looking statement that involves known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. The Company assumes no obligations to update the forward-looking statements contained herein to reflect actual results, changes in assumptions or changes in factors affecting these statements.

This presentation does not constitute or form part of, and is not prepared or made in connection with, an offer or invitation to sell, or any solicitation of any offer to subscribe for or purchase any securities and nothing contained herein shall form the basis of any contract or commitment whatsoever. No reliance may be placed for any purposes whatsoever on the information contained in this presentation or on its completeness, accuracy or fairness. The information in this presentation is subject to verification, completion and change. The contents of this presentation have not been independently verified. While the Company relies on information obtained from sources believed to be reliable, it does not guarantee its accuracy or completeness. Accordingly, no representation or warranty, express or implied, is made or given by or on behalf of the Company or any of its owners, directors, officers or employees or any other person as to the accuracy, completeness or fairness of the information or opinions contained in this presentation. None of the Company, its affiliates or any of their respective advisors or representatives or any other person shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with the presentation. The Company's securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), and are offered and sold only outside the United States in accordance with an exemption from registration provided by Regulation S of the US Securities Act.

This presentation should not form the basis of any investment decision. Investors and prospective investors in securities of any issuer mentioned herein are required to make their own independent investigation and appraisal of the business and financial condition of such company and the nature of the securities. Any decision to purchase securities in the context of a proposed offering of securities, if any, should be made solely on the basis of information contained in any offering documents published in relation to such an offering. For further information about the Company, reference is made public disclosures made by the Company, such as filings made with the Oslo Stock Exchange, periodic reports and other materials available on the Company's web pages.

Our DNA

Vision

The Challenger

Business Idea

This will happen through unique relationships, best in class decisionmaking and cost effective solutions

Main targets

Cost and quality leadership

Profitable growth

Top 3

Values

Credible

Innovative/Open

Bold

Committed

Other highlights:

  • Large losses in quarter higher than normalised
  • Ceding w.r.t. our Solvency Based Reinsurance Agreement reduced from 10 % to 8 %
  • Special dividend of 1.5 NOK per share MNOK 124

206%

200% *

150%

Q1 '22

180%

Q4 '21

This presentation contains alternative performance measures (APMs). APMs are described here: https://protectorforsikring.no/en/investor/documents/spreadsheets/

* Post special dividend

Claims update

• Large losses1 at 10.7 % (1.2 %), 3.7 %-points higher than normalized

• Net run off gains at 3.6 % in Q1 22 (0.1 % in Q1 21)

  • Zero aggregated COVID-19 effects in quarter
  • 2 %-points positive net effect in Q1 21

Large losses1 and run-off

  • Net large losses of MNOK 144, or 10.7 % in Q1 22
  • One very large fire in Sweden (Property)
  • UK Storm Eunice, 14th -19th February '22

    • 84 accumulated claims
  • Net run off gains at 3.6 % in Q1 22 (gain of 0.1 % in Q1 21)

  • Whereof 1.1 %-points are directly linked to large losses from earlier years

6

  • GWP of MNOK 3 111 in Q1 2022 (MNOK 2 880)
  • MNOK 230 (8%) growth (11% in LCY)
  • Growth driven by Scandinavia
  • Supported by price increases above claims inflation
  • Low client churn
    • Renewal rate at 90.7%
  • Small volume quarter for UK
MNOK
Business unit Q1 22 $\overline{Q1\,21}$ Growth $$ NOK $%$ $$ LCY $%$
Norway 955 856 99 12% 12%
Sweden 943 895 48 5% 13%
Denmark 812 727 85 12% 16%
UK 196 238 $-42$ $-18%$ $-19%$
Finland 204 164 40 24% 29%
Protector 3 1 1 1 2880 230 8% 11%

Country-by-country key metrics

Quarterly volatility must be expected, especially by country

Q1 2022

Norway Sweden Denmark UK Finland Protector
l MNOK Q1 22 Q1 21 Q1 22 Q1 21 Q1 22 Q1 21 Q1 22 Q1 21 Q1 22 Q1 21 Q1 22 Q1 21
Gross premium written 955 856 943 895 812 727 196 238 204 164 3 1 1 1 2880
Gross premium earned 372 343 449 434 244 207 387 334 72 70 1525 1 388
Net premium earned 338 305 411 373 219 180 303 254 66 62 1 337 1 1 7 5
Gross claims ratio 89.0% 68.1% 86.6% 61.1% 96.6% 103.6% 66.1% 75.2% 81.1% 101.6% 83.3 % 74.6 %
Gross cost ratio 6.9% 8.9% 12.3 % 14.7 % 7.4 % 10.4 % 13.2 % 18.5 % 3.5% 8.2% 10.0 % 13.2 $%$
Gross combined ratio 95.8% 77.0% 98.9% 75.7 % 104.0% 114.0 % 79.3 % 93.7 % 84.7 % 109.8% 93.3 % 87.8%
Net claims ratio 91.9% 83.7% 85.8% 65.1% 99.3% 84.1% 73.9% 83.2% 81.4 % 98.3% 86.6% 78.5 %
Net cost ratio 6.9% 10.5 % 12.4 % 13.3 % 8.4 % 6.5% 14.9 % 19.0% 2.4 % 9.2% 10.4 % 12.6 $%$
$\mid$ Net combined ratio 98.9% 94.2 % $98.1\%$ 78.4 % 107.7 % $\leftarrow$ 90.6 % 88.7% 102.2% 83.8% 107.5% $97.0\%$ 91.1%

Target: Nr 1 in all markets on Quality and Claims

Behind target in Scandinavia. Nr 1 position requires a thorough understanding and actions.

Norway 2022 Target '22 2021/20 2019/18 2017
Tender & new sales 79 80 78 75 69
Customer care and service 80 80 79 75 69
Claims Handling 70 75 70 69 68
BSI Total quality leader 1st 1st 2nd 1st 1st
BSI Claims Handling quality leader 2nd 1st 6th 2nd 1st
Sweden 2022 Target '22 2021/20 2019/18 2017
Tender & new sales 72 80 73 75 78
Customer care and service 75 80 74 77 79
Claims Handling 61 75 60 60 72
BSI Total quality leader 3rd 1st 4th 1st 1st
BSI Claims Handling quality leader 4th 1st 5th 2nd 1st
Denmark 2022 Target '22 2021/20 2019/18
Tender & new sales 69 78 63 73 63
Customer care and service 68 75 61 69 60
Claims Handling 66 70 59 71 61
BSI Total quality leader 2nd 1st 3rd 1st 1st
BSI Claims Handling quality leader 3rd 9
1st
2nd 3rd 1st

Our DNA

Vision

The Challenger

Business Idea

This will happen through unique relationships, best in class decisionmaking and cost effective solutions

Main targets

Cost and quality leadership

Profitable growth

Top 3

Values

Credible

Innovative/Open

Bold

Committed

Investment performance and statistics

-0,1 % return in Q1 | Bond portfolio yield at 2.4 %, before cost of risk

  • Q1 return on investment portfolio at -0.1 %, or MNOK -10
  • Equity portfolio returning -0,3 %, or MNOK -7
  • Bond portfolio returning 0.0 %, or MNOK 2
  • Return of put options MNOK -6

  • HY portfolio totalling BNOK 3.2 vs. BNOK 3.5 in Q4 '21

  • Nordic high yield: volatile, but calmer towards quarter-end
    • DNB Markets Nordic HY index return -0.5 %
  • Equity share at 16.2 %, up from 15.1 % in Q4 '21
  • 12 new companies and MNOK 300 invested since 24.02.22
  • Limited direct exposure to Ukraine / Russia
Investment portfolio data2 31.03.22 31.03.21 31.12.21
Size bond & cash eq. (MNOK) 12 368 12 472 12 003
Avg. ref. rate (NIBOR, STIBOR, etc.) 0.9 % 0.1 % 0.5 %
Avg. spread/risk premium (bps) 152 179 151
Bonds Yield 2.4% 2.0% 2.0%
Duration 0.4 0.4 0.4
Credit duration 1.1 1.4 1.3
Avg. rating3 A A- A
Portfolio
size4
2
400
2 413 2
166
Equities Share of total 16.2 % 16.2 % 15.1 %
Estimated
intrinsic value discount
33 % 15 % 26 %
No. of companies 32 20 20

1 Equity return excludes results from put options, total return includes results from put options 2 Includes bank deposits and excludes currency swap contracts

3Avg. linear rating based on official rating (>55 %) and 'Protector rating' (<45 %)

4 Portfolio size based on book values (B3 Consulting Group booked using equity method (associated company)

Our DNA

Vision

The Challenger

Business Idea

This will happen through unique relationships, best in class decisionmaking and cost effective solutions

Main targets

Cost and quality leadership

Profitable growth

Top 3

Values

Credible

Innovative/Open

Bold

Committed

Balance Sheet SCR ratio at 200% post dividend

In millions 31.03.2022 31.03.2021 31.12.2021
Financial assets 13 840 13 400 13 067
Derivatives 92 73 94
Bank deposits 166 165 300
Other assets 4 648 4 495 4 338
Discontinued
operations
1 245 1 876 1 448
Total assets 19 991 20 011 19 246
Total equity 3 290 3 585 3 582
Subordinated loan capital 1 245 1 473 1 385
Total reserves 11 501 10 520 9 980
Derivatives 117 60 26
Other liabilities 3 139 3 349 3 440
Discontinued operations 698 1 024 834
Total equity and liabilities 19 991 20 011 19 246

Numbers may not add up due to rounding

  • Positive contribution from technical result and negative contribution from investment result
  • Positive effect from change in discounting rates
  • Negative effect on SCR ratio from proposed dividend of NOK 1.50 per share

13

SCR OF

Solvency II SCR ratio at 200% post dividend

Composition of SCR:

  • Net insurance risk 62%
  • Net market risk 29%
  • Other risks 9%

14

  • Accumulated dividend subtracted from eligible capital
  • Guarantee provision subtracted from own funds

SCR composition

Eligible solvency capital

MNOK Q1 22 Q1 21 FY 21
Gross premiums written 3 1 1 1 2880 5951
Earned premiums, net of reinsurance 1 3 3 7 1 1 7 5 4921
Claims incurred, net of reinsurance (1158) (923) (3 810)
Sales cost (93) (101) (362)
Administration cost (60) (82) (257)
Commission from reinsurer 13 36 131
Other insurance related income/expenses (8) (13) (29)
Technical result 32 92 594
Other income/costs (14) (17) (56)
Net financial income (9) 523 878
Profit before tax 8 598 1416
Tax (25) (71) (252)
Discontinued operations (3) 51 67
Net comprehensive income (24) (5) (28)
Profit for the period (45) 573 1 2 0 4
Claims ratio, net of reinsurance 86.6% 78.5 % 77,4 %
Expense ratio, net of reinsurance 10.4% 12.6 % 9,9%
Combined ratio, net of reinsurance 97.0% 91.1% 87,3%
Gross claims ratio 83.3 % 74.6 % 77,8%
Gross expense ratio 10.0% 13.2 % 10,8%
Gross combined ratio 93.3 % 87.8% 88,5%
Retention rate 87.6% 84.7% 85,6%
Earnings per share $-0.2$ 7.0 0,0

Dividend policy A special dividend of NOK 1.50 per share – Flexible shareholder distribution policy

Solvency II ratio

Current level
= 200%
180%

Capital over 180% in SCR ratio distributed over time
Normal Range
Shareholder distribution normally 20%-80% of net profit

Quarterly decisions, all allocation alternatives evaluated

Profitable insurance growth always prioritized
150%
Build solvency capital, any shareholder distribution only
after a careful consideration
  • Special dividend of MNOK 124 (NOK 1.50 per share); to be paid out around 12 May (ex. dividend 4 May)
  • Quarterly assessment continued going forward
Q1
• Net combined ratio 97 %
• Gross written premium MNOK 3 111
$(+8%)$
• Investment return MNOK-10
$(-0.1 %)$
• Profit for the period MNOK-45
• Earnings per share NOK-0.2
• Solvency Capital Ratio ንበበ%

This presentation contains alternative performance measures (APMs). APMs are described here: https://protectorforsikring.no/en/investor/documents/spreadsheets/

$\Delta$

$\bigcup$

Talk to a Data Expert

Have a question? We'll get back to you promptly.